IGF-1 LR3 Dosage and Protocols
IGF-1 LR3 dosage protocols reported in published research, plus reconstitution and storage.
Research Protocol Doses Reported in Published Literature
Research Disclaimer: Doses reported below are from published preclinical research protocols. IGF-1 LR3 is not approved for human use by the FDA or any regulatory agency. This information is provided for research reference only and does not constitute a dosing recommendation. All doses above are reported from published research protocols using laboratory subjects. Refer to the cited studies in the Research Studies section above for original source data.
Reported protocol doses
Reconstitution
A 1mg vial with 1mL of bacteriostatic water is the pairing reported most often. 1mg vial + 1mL bacteriostatic water = 1000mcg/mL. A 20mcg dose is 0.02mL (2 units).
Work out your own concentration with the reconstitution calculator.
Doses shown are those reported in published research, not a recommendation.
References
- Insulin-like growth factor I and muscle growth · Adams GR · 2002
- Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice. · Engel MG, Narayan S, Cui MH et al. · 2025
- Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical ... · Bailes J, Soloviev M · 2021
- IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep. · White A, Stremming J, Wesolowski SR et al. · 2025
- IGF-1 Has Plaque-Stabilizing Effects in Atherosclerosis by Altering ... · von der Thüsen JH, Borensztajn KS, Moimas S, van Heiningen S, Teeling P, van Berkel TJ, Biessen EA · 2011
- Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration. · Yavuz E, Sağır MS, Ercan A et al. · 2025